| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $201.3M | +7.8% |
| R&D Expense | $58.9M | -12.9% |
| SG&A Expense | $75.9M | +0.5% |
| Operating Income | -$14.2M | +52.7% |
| Pre-tax Income | -$20.8M | +44.4% |
| Income Tax | $205K | -36.9% |
| Net Income | -$20.9M | +44.2% |
| EPS (Basic) | -$0.11 | +47.6% |
| EPS (Diluted) | -$0.11 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.3M | +74.0% |
| Accounts Receivable | $29.8M | -16.1% |
| Inventory | $38.1M | -4.3% |
| Current Assets | $152.0M | +5.2% |
| Total Assets | $200.9M | +1.6% |
| Current Liabilities | $63.6M | -5.8% |
| Total Liabilities | $144.0M | -0.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.4M | +126.3% |
| Capital Expenditures | $2.8M | -38.3% |
| Investing Cash Flow | -$8.1M | -194.3% |
| Financing Cash Flow | $5.0M | -53.5% |
| Free Cash Flow | $8.5M | +117.8% |
| +47.6% |
| Stockholders' Equity |
| $56.1M |
| +6.6% |